South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and ...

GE HealthCare buys SOFIE Biosciences for $945 M to establish 'Final Mile' footprint for PET Radiopharmaceutical Supply in US ...

Charles River and Autolomous launch Apollo Orchestrate to digitize GMP laboratory execution and connect biologics testing workflows in North America and Europe.

Andelyn Biosciences and PQP Group have partnered to streamline cell and gene therapy supply to the EU and UK, integrating ...

China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered into a ...

NUS launches S$50M National Centre for Engineering Biology to accelerate AI-guided sustainable biomanufacturing ...

Docquity, the Singapore-based clinical AI platform for more than 75% of verified doctors across Asia, has announced its scale ...

BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokohama, 7 to 9 October Forty years after its first edition in 1986, BioJapan opened its 2026 edition at PACIFICO Yokohama on ...

Germfree has launched a configurable Grade A aseptic biopharmaceutical isolator designed to support contamination control and ...

Hengrui Pharma and Novo Enter ink $2.6billion deal for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596 ...

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, US.

Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, US. Building ...